Acadia Healthcare Company, Inc.

ACHC Healthcare Medical Care Facilities

Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024.

Revenue
+5.14%
EPS
−5.00%
Free cash flow
+196.5%
Total debt
+1.87%

Quarter to September 2026, against a year earlier

37.18 2.39 +6.87%
Market cap
$3.2B
P/E
0.0×
Fwd P/E
34.4×
Dividend yield
—
F-score
5/9
Altman Z
0.92
Beneish M
−3.58
Dividend safety
2/100

Acadia Healthcare Company, Inc. (ACHC) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Acadia Healthcare Company, Inc. (ACHC) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 1.0× (January 2026) to 5.9× (June 2015); the current reading is higher than 14% of that period. That is above the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.1× (36.90%)
FY2024 1.7× (38.97%)
FY2023 2.9× (13.00%)
FY2022 3.3× 12.87%
FY2021 2.9× (14.90%)
FY2020 3.4× 15.51%
FY2019 3.0× 4.92%
FY2018 2.8× 31.25%
FY2017 2.2× 0.13%
FY2016 2.2× (40.42%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.4× (6.02%)
Jun 2026 1.5× 9.90%
Mar 2026 1.3× 20.64%
Dec 2025 1.1× (18.68%)
43 more quarters

Against its own ten years

Low 1.0× High 5.9×
Ten-year median 2.9×
Current reading's percentile 15

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ACHC